Wenjin Cao

Wenjin Cao is an experienced professional in the biopharmaceutical industry, currently serving as Associate Director of Quality Operations at Atara Biotherapeutics since September 2019. Previously, Wenjin held the position of Director at ArmaGen, Inc., overseeing biopharmaceutical development and clinical supply from October 2017 to March 2019. At Amgen, from July 2002 to September 2017, Wenjin advanced from Scientist to Principal Scientist, contributing to the development of pipeline products including monoclonal antibodies, fusion proteins, and antibody-drug conjugates, as well as focusing on protein formulation. Wenjin earned a Ph.D. in Industrial and Physical Pharmacy from Purdue University and a BS in Pharmacy from China Pharmaceutical University.